Clinical Trials Browser

Recruiting × Uterine Cervical Neoplasms × Immunotherapy × Clear all

NCT07130240 2025-08-19

Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT06878222 2025-04-01

Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC

Phase 2 Recruiting

Uterine Cervical Neoplasms